Biocept reports inducement grants under nasdaq listing rule 5635(c)(4)

San diego--(business wire)--biocept, inc. (nasdaq: bioc), a leading provider of molecular diagnostic assays, products and services, today announced that it has granted inducement stock options to purchase an aggregate of 89,550 shares of its common stock to 12 new employees. the inducement stock options have a grant date of august 31, 2022 and were granted as inducements material to the new employees entering into employment with biocept in accordance with nasdaq listing rule 5635(c)(4). the in
BIOC Ratings Summary
BIOC Quant Ranking